Ispire Technology Inc. (ISPR)
NASDAQ: ISPR · Real-Time Price · USD
1.460
+0.030 (2.10%)
At close: Sep 11, 2026, 4:00 PM EDT
1.490
+0.030 (2.05%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Ispire Technology Revenue
Ispire Technology had revenue of $18.69M in the quarter ending March 31, 2026, a decrease of -28.66%. This brings the company's revenue in the last twelve months to $89.46M, down -38.18% year-over-year. In the fiscal year ending June 30, 2025, Ispire Technology had annual revenue of $127.49M, down -16.07%.
Revenue (ttm)
$89.46M
Revenue Growth
-38.18%
P/S Ratio
0.96
Revenue / Employee
$1,104,449
Employees
81
Market Cap
85.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 127.49M | -24.41M | -16.07% |
| Jun 30, 2024 | 151.91M | 36.30M | 31.40% |
| Jun 30, 2023 | 115.61M | 27.51M | 31.23% |
| Jun 30, 2022 | 88.10M | 24.68M | 38.92% |
| Jun 30, 2021 | 63.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Philip Morris International | 42.55B |
| British American Tobacco p.l.c. | 34.20B |
| Altria Group | 20.44B |
| Universal | 2.85B |
| RLX Technology | 662.65M |
| Turning Point Brands | 507.23M |
| RYTHM | 51.01M |
| 22nd Century Group | 5.17M |
ISPR News
- 3 days ago - Ispire Technology Inc. Schedules Fiscal Fourth Quarter and Full Year 2026 Earnings Conference Call - Accesswire
- 26 days ago - Ispire Technology Inc. Appoints Steven Przybyla as President - PRNewsWire
- 7 weeks ago - Ispire Technology initiated with a Buy at BTIG - TheFly
- 2 months ago - Ispire Technology Transcript: AGM 2026 - Transcripts
- 4 months ago - Ispire Technology forms joint venture to enter nicotine pouch market - TheFly
- 4 months ago - Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma - PRNewsWire
- 4 months ago - Ispire Technology Proxy statement: Proxy filing - Filings
- 4 months ago - Ispire Technology Proxy statement: Proxy filing - Filings